DCO
T2Ducommun Incorporated
OverviewDucommun Incorporated engineers and manufactures products for aerospace and defense, industrial, and medical sectors. Its Electronic Systems provide complex ele
Ducommun Incorporated engineers and manufactures products for aerospace and defense, industrial, and medical sectors. Its Electronic Systems provide complex electronic components and interconnects, while Structural Systems deliver aero structure components and assemblies. The company primarily serves commercial and military aircraft, space programs, and defense primes like Raytheon, with over 85% of revenue from the U.S.
- What They Do (Plain English & Analogies)
- Ducommun Incorporated is like a specialized parts manufacturer for high-tech vehicles and equipment, primarily for airplanes, spacecraft, and military systems. Imagine a company that makes the intricate wiring harnesses that connect all the electronics in a fighter jet, or the strong, lightweight structural pieces that form part of a commercial airliner's wing. They also produce sophisticated electronic components like switches and filters for radar systems, and even motors that control movement in complex machinery. They essentially provide the critical, often custom-engineered, guts and bones for advanced aerospace and defense applications, as well as some industrial and medical uses.
- Very Brief History
- Founded in 1849, Ducommun Incorporated has a long history, evolving into a key supplier of engineered products and services for the aerospace and defense industries. In recent years, the company has embarked on a 'Vision 2027' strategic plan, initiated in late 2022, focusing on increasing revenue from engineered products and aftermarket content, consolidating its manufacturing footprint, and pursuing strategic acquisitions like BLR in 2023.
- "Street Stereotype"
- The street generally perceives Ducommun as a company in transition, moving from a legacy structures manufacturer to a higher-growth aerospace and defense technology provider, particularly in high-margin electronic systems and defense-related actuator hardware. Investors have historically noted inconsistent margin execution, leading to a valuation discount compared to peers. However, with the 'Vision 2027' strategy, the market is looking for improved operational leverage and margin expansion to justify a rerating.
- Subsidiaries On Linked In*
- None (Ducommun operates primarily under its single corporate brand, with various 'Performance Centers' or divisions rather than distinct, separately branded subsidiaries on LinkedIn. While they acquire companies like BLR, these are typically integrated into their existing operational structure).
- Customer Sectors & Example Clients
- Ducommun's customers are primarily in the aerospace and defense, industrial, and medical sectors. Top clients include major defense primes and aerospace manufacturers such as Raytheon, Lockheed Martin, Boeing, and Airbus.
- New Customers / Segments They'Re Targeting
- Ducommun is actively targeting new opportunities within the defense sector, particularly in high-growth segments like missiles, hypersonics, and counter-hypersonic programs, as well as the CCA (Collaborative Combat Aircraft) warfare program. They are also focused on expanding their content on key commercial aerospace platforms and increasing their presence in the humanoid actuator market and other high-growth robotics and defense applications.
- How Key Themes May Help/Hurt
- Ducommun is well-positioned to benefit significantly from the buildout of motion control technologies. As a supplier of motors and resolvers for motion control within its Electronic Systems segment, the company stands to gain from rising AI-related capital expenditure in robotics, defense, aerospace, and industrial automation. The secular adoption of robotics, including humanoid robots and warehouse automation, requires high-end bearings and actuators, creating structural demand for Ducommun's precision motion components. Expanding fiscal and defense budgets tied to AI/automation further ensure sustained demand. While the industrial cycle's fragility or delays in AI capex could pose a near-term risk, the long-term trend is a strong tailwind for DCO.
3 Main Long-Term Bull Details
- Strong Defense and Missile Growth: Ducommun is a critical supplier on over a dozen key missile platforms, and the Department of War's push to significantly increase missile production capacity, supported by long-term framework agreements with primes like Raytheon and Lockheed Martin, presents a substantial growth catalyst starting in 2027 and beyond. The company has significant existing capacity and minimal CapEx needs to meet this demand.
- Engineered Products and Margin Expansion: The company's 'Vision 2027' strategy is successfully driving an increase in the percentage of engineered products and aftermarket content, which reached 23% in 2025, up from 15% in 2022. This focus, combined with strategic value pricing, restructuring actions, and productivity improvements from facility consolidations, is leading to record gross and adjusted EBITDA margins, positioning DCO to meet and exceed its Vision 2027 margin goals.
- Commercial Aerospace Recovery: Despite destocking headwinds in 2025 and early 2026, Ducommun anticipates a recovery in its commercial aerospace business in the second half of 2026, driven by increasing Boeing 737 MAX build rates and significant investments in 787 production. As a key supplier with substantial content on these platforms, the eventual ramp-up will provide significant revenue growth opportunities.
3 Main Long-Term Bear Details
- Commercial Aerospace Destocking and Production Volatility: While a recovery is anticipated, destocking at major customers like Boeing and Spirit on the 737 MAX platform is expected to persist through the first half of 2026, creating a near-term headwind. Any further delays or production issues in commercial aerospace could negatively impact revenue and profitability.
- Execution Risk in Capacity Ramp-up and Integration: Although Ducommun states it has sufficient capacity for missile production increases and has completed facility consolidations, the successful ramp-up to full production rates at new locations (e.g., Tomahawk components in Joplin, Missouri) and the full realization of projected cost savings ($11 million to $13 million annually) still carry execution risk.
- Geopolitical and Economic Uncertainties: The company faces risks from the cyclicality of its end-use markets, the level of U.S. government defense spending, international trade restrictions, the impact of tariffs and elevated interest rates, and broader economic and geopolitical developments, including supply chain issues. These factors could disrupt demand or increase operational costs.
- Competitors And Differentiation
- While the transcript does not explicitly name direct competitors, Ducommun operates in a competitive landscape alongside precision component suppliers in the aerospace and defense sector. Peers often mentioned include Curtiss-Wright and RBC Bearings. Ducommun differentiates itself by focusing on increasing its engineered products and aftermarket content, executing an offloading strategy with defense primes, driving value-added pricing, and expanding content on key commercial aerospace platforms. Their strategic facility consolidation and strong relationships as an existing supplier on numerous critical defense programs also provide a competitive edge.
- Recent Performance & What The Market'S Focused On
- Ducommun reported a strong Q4 2025, achieving record quarterly revenues of $215.8 million (up 9.4% year-over-year) and its 19th consecutive quarter of year-over-year revenue growth. Gross margins reached a record 27.7%, and adjusted EBITDA hit 17.5%. Full-year 2025 revenue grew 5% to a record $825 million, with military and space business growing 14%. The company also achieved a record remaining performance obligation (RPO) of $1.1 billion and a Q4 book-to-bill of 1.3x. The market is focused on the continued execution of the 'Vision 2027' strategy, particularly the expansion of engineered product revenues and margin improvement towards the 18% adjusted EBITDA target. Key areas of market focus include the timing and magnitude of the commercial aerospace recovery, the ramp-up in missile production and its impact on defense segment growth, and the company's M&A strategy to achieve its revenue contribution placeholder.
- Brands And Revenue Segments
- Ducommun operates under the primary brand Ducommun Incorporated. Its revenue is generated through two main segments: * **Electronic Systems:** This segment provides cable assemblies, interconnect systems, printed circuit board assemblies, higher-level electronic, electromechanical, and mechanical components, lightning diversion systems, radar enclosures, aircraft avionics racks, shipboard communications and control enclosures, illuminated pushbutton switches and panels, microwave and millimeter switches and filters, and motors and resolvers for motion control. In Q4 2025, this segment posted revenue of $120 million. * **Structural Systems:** This segment designs, engineers, and manufactures contoured aluminum, titanium, and Inconel aero structure components; structural assembly products (e.g., winglets, engine components, fuselage structural panels); and metal and composite bonded structures and assemblies (e.g., aircraft wing spoilers, large fuselage skins, rotor blades, flight control surfaces, ammunition handling systems, magnetic seals). In Q4 2025, this segment posted revenue of $96 million.
Bull / Bear DetailsDucommun is a compelling investment driven by strong execution of its Vision 2027 strategy, evidenced by record Q4 2025 revenue and margins. Robust defense spen
Thesis
Ducommun is a compelling investment driven by strong execution of its Vision 2027 strategy, evidenced by record Q4 2025 revenue and margins. Robust defense spending, particularly in missile programs, and an anticipated H2 2026 commercial aerospace recovery, position DCO for continued growth. The focus on high-value engineered products and strategic acquisitions underpins its long-term margin expansion and market share gains. (Updated: February 27, 2026)
Bull case
Ducommun demonstrates strong top-line momentum and backlog visibility, with record Q4 2025 revenue and its 19th consecutive quarter of year-over-year growth. The company achieved a robust 1.3x book-to-bill in Q4, driving Remaining Performance Obligations to a new record of $1.1 billion. This growth is significantly fueled by its military and space segment, particularly strong missile program bookings and anticipated ramp-ups.
Operational efficiency and strategic focus on engineered products are driving significant margin expansion. Ducommun achieved record gross and adjusted EBITDA margins in Q4 2025, reaching 17.5%, demonstrating strong progress towards its Vision 2027 target of 18%. The completed restructuring program is on track to deliver $11 million to $13 million in annual savings by year-end 2026, further bolstering profitability.
The commercial aerospace segment is poised for a strong recovery in the second half of 2026, following a return to growth in Q4 2025. Expected increases in Boeing's 737 MAX and 787 build rates, coupled with the resolution of destocking issues, will provide a significant tailwind. Ducommun's substantial content on key platforms like the 787 positions it to capitalize on this industry rebound.
Bear case
The commercial aerospace segment continues to face headwinds from destocking at major customers like Boeing and Spirit, which is expected to persist through the first half of 2026. This prolonged destocking could delay the anticipated revenue ramp-up and impact overall commercial aerospace performance, potentially slowing the company's progress towards its Vision 2027 revenue targets.
Ducommun's Vision 2027 revenue targets rely on a $75 million contribution from M&A, which management confirms will require further acquisitions. However, the M&A market is competitive with high valuations, posing a risk to achieving these targets. The challenge of identifying and successfully integrating accretive acquisitions at reasonable prices could hinder overall strategic growth.
While Q4 2025 margins were strong, they benefited from an atypical favorable product mix, contributing approximately 100 basis points. The baseline adjusted EBITDA margin for 2026 is expected to be closer to 16.5%, implying that sustaining or rapidly expanding margins towards the 18% Vision 2027 target will require consistent operational execution and a favorable product mix, which may not always be present.
Bull / Bear Case
- Bear Case
- Despite strong Q4 2025 results, Ducommun faces headwinds, particularly in its commercial aerospace segment, where destocking at major customers like Boeing and Spirit is expected to persist through the first half of 2026. This prolonged destocking could delay the anticipated revenue ramp-up and impact overall commercial aerospace performance, potentially slowing progress towards Vision 2027 revenue targets. Furthermore, achieving the $75 million M&A revenue contribution outlined in Vision 2027 is reliant on further acquisitions in a competitive market with high valuations, posing execution risk and potential for overpaying. While Q4 2025 margins were strong, they benefited from an atypical favorable product mix (approximately 100 basis points), suggesting that sustaining rapid margin expansion towards the 18% Vision 2027 target will require consistent operational execution and favorable conditions that may not always be present.
- Bull Case
- Ducommun is positioned for continued growth, driven by robust execution of its Vision 2027 strategy, which focuses on increasing engineered products and aftermarket content. The company reported record Q4 2025 revenues, marking its 19th consecutive quarter of year-over-year growth, and achieved record gross and adjusted EBITDA margins of 27.7% and 17.5%, respectively. Strong defense spending, particularly in missile programs, is a significant tailwind, with RPOs reaching a record $1.1 billion and a Q4 book-to-bill of 1.3x. The commercial aerospace segment, despite prior challenges, returned to growth in Q4 2025 and is anticipated to recover strongly in the second half of 2026 as Boeing's build rates increase and destocking resolves. Completed restructuring initiatives are expected to yield $11 million to $13 million in annual savings by year-end 2026, further boosting profitability.
- More Compelling & Why
- Bear. The current stock price of DCO, trading near its 52-week high with an average analyst price target suggesting only a modest upside (around 3-5%), indicates that much of the anticipated growth and margin expansion is already priced in. The strongest argument for the bear case is the persistent commercial aerospace destocking through H1 2026 and the reliance on M&A for Vision 2027 revenue targets in a competitive market with high valuations, which presents execution risk. My view would flip to Bull if DCO consistently exceeds its Adjusted EBITDA margin targets (e.g., above 17% without atypical mix benefits) in the first half of 2026, demonstrating strong operational leverage and effective mitigation of commercial aerospace headwinds, and if the company successfully announces accretive acquisitions that significantly contribute to the Vision 2027 revenue target without overpaying.
Key Factors
| Key Factor | Why It Matters | What To Watch | What It Signals | Where/How To Track | Free Alt Data | Paid Alt Data |
|---|---|---|---|---|---|---|
| Defense Missile Program Bookings and Backlog Growth | Strong bookings in defense missile programs provide long-term revenue visibility, validate Ducommun's strategic positioning, and indicate the company's ability to capitalize on increased defense spending and capacity ramp-ups. | Quarterly bookings for missile programs (e.g., MIR, Tomahawk, AMRAAM, PAC-3, THAAD, SM3, Standard Missiles). Overall company book-to-bill ratio and Remaining Performance Obligations (RPOs). | Bullish: Quarterly missile bookings exceeding Q4 2025's >$130 million, or a sustained company-wide book-to-bill ratio above 1.3x, and RPOs growing sequentially beyond $1.1 billion. | Company earnings calls, press releases, Form 10-Q/K filings. | USASpending.gov: Government contract awards for missile programs involving Raytheon, Lockheed Martin, and Ducommun. | GovWin IQ: Defense contract awards and spending forecasts. |
| Achievement of Vision 2027 Engineered Products Revenue Target and Vision 2032 Presentation | Reaching the Vision 2027 target for engineered products revenue percentage demonstrates successful strategic transformation towards higher-value offerings. The Vision 2032 presentation will outline the company's long-term growth strategy and financial goals, impacting future valuation. | The reported percentage of revenue from engineered products and aftermarket content in upcoming quarters, aiming to exceed 25%. Details and content of the Vision 2032 presentation on September 17th. | Bullish: Exceeding the 25% engineered products revenue target ahead of 2027. A compelling Vision 2032 plan presented in September with ambitious yet achievable growth and margin targets. Bearish: Stagnation or decline in the engineered products revenue percentage. A Vision 2032 plan that lacks clear strategic direction or aggressive growth targets. | Company earnings calls, investor presentations, press releases, especially around the September 17th investor conference. | Company investor relations website for presentation materials. | |
| Commercial Aerospace Build Rate Increases and Destocking Resolution | The resolution of destocking and successful ramp-up of commercial aerospace build rates, particularly for Boeing 737 MAX and 787, are crucial for Ducommun's commercial segment revenue growth and overall top-line acceleration. | Boeing 737 MAX build rates (target 42, then 47 later in 2026), Boeing 787 production rates (target 10 per month by year-end 2026), and Ducommun's commercial aerospace revenue growth in H2 2026. | Bullish: Boeing achieving or exceeding planned 737 MAX and 787 build rates, leading to Ducommun's commercial aerospace revenue growth returning to mid-single digits or higher in H2 2026. Bearish: Delays in Boeing's production ramp-up or continued significant destocking beyond H1 2026. | Boeing and Airbus earnings calls, industry reports (e.g., from IATA, aerospace analysts), Ducommun's future earnings calls. | FlightAware: Commercial aircraft delivery data. Boeing/Airbus investor relations for production rate updates. | Teal Group: Aerospace market analysis and forecasts. Ascend by Cirium: Aircraft fleet and delivery data. |
| Realization of Restructuring Program Savings | The successful realization of the remaining $6M-$7M in annual savings from restructuring initiatives is critical for driving further gross and Adjusted EBITDA margin expansion and achieving Vision 2027 profitability targets. | Management commentary on the progress of realizing the remaining $6M-$7M in annual savings, and the impact on gross and operating margins in 2026, particularly in H2 2026 as facilities reach full production. | Bullish: Confirmation of achieving the full $11M-$13M run rate savings by end of 2026, with a clear positive impact on reported margins. Bearish: Delays or shortfalls in realizing the remaining $6M-$7M in savings, impacting margin expansion. | Company earnings calls, press releases, Form 10-Q/K filings. | ||
| Adjusted EBITDA Margin Trajectory towards Vision 2027 Target | Sustained Adjusted EBITDA margin expansion demonstrates Ducommun's operational efficiency, successful integration of restructuring savings, and the positive impact of its engineered products strategy on profitability, crucial for valuation rerating. | Quarterly Adjusted EBITDA margin, particularly the trend excluding one-time benefits, and progress towards the 18% Vision 2027 target. | Bullish: Quarterly Adjusted EBITDA margin consistently above the 16.5% baseline, showing clear progress towards the 18% Vision 2027 target, driven by operational improvements and favorable mix. Bearish: Adjusted EBITDA margin falling below 16.0% or showing stagnation, indicating challenges in realizing cost savings or achieving favorable product mix. | Company earnings calls, press releases, Form 10-Q/K filings. | Company investor presentations and financial reports. | S&P Capital IQ: Financial statement analysis and consensus estimates for EBITDA margins. |
Key Reported Metrics
| Metric | Why It Matters | Last Period |
|---|---|---|
| Total Revenue | Revenue growth reflects Ducommun's ability to capitalize on the commercial aerospace recovery and robust defense budgets. Investors are specifically watching for top-line acceleration as supply chain constraints ease and the company's engineered products gain traction in high-growth robotics and defense applications. | 9.4% |
| Adjusted EBITDA Margin | Adjusted EBITDA margin growth measures operational efficiency and the success of the company's 'Engineered Products' strategy. Investors focus on this to ensure that higher-value components are translating into superior bottom-line performance and margin expansion. | 26.44% |
| Military and Space Revenue | This segment is a key driver of Ducommun's growth, benefiting from robust defense spending and missile production ramp-ups. Its continued strength is crucial for overall revenue acceleration and achieving strategic goals. | 13% |
Key QuestionsWill the commercial aerospace segment's destocking headwinds in the first half of 2026 be more severe or less impactful than anticipated, influencing the projec
Will the commercial aerospace segment's destocking headwinds in the first half of 2026 be more severe or less impactful than anticipated, influencing the projected second-half recovery?
- Question 2
Can Ducommun sustain its strong defense bookings momentum and demonstrate initial production ramp-up on key missile programs in Q1 2026, providing further confidence in the 2027 growth catalyst?
- Question 3
Will Ducommun's Adjusted EBITDA margins in Q1 2026 show continued expansion from the 2025 baseline of 16.4%, driven by the realization of remaining restructuring savings and favorable operational execution, without the benefit of Q4's atypical product mix?
Rerating Thresholds
| Metric | What'S Needed For Rerating | Why It Matters | Earnings Date |
|---|---|---|---|
| Total Revenue | To achieve a higher rerating, Ducommun needs to demonstrate revenue growth acceleration to a range of 8% to 10% year-over-year, effectively moving past the current stagnant 1.1% level. Specifically, the company needs to report quarterly revenue exceeding $215 million, which would represent a 3-5% beat over current consensus estimates. This growth must be driven by organic expansion in the Electronic Systems segment, particularly within high-margin motion control and actuator hardware, to align with the 'Vision 2027' target of $950M-$1B in annual revenue. | Revenue acceleration validates Ducommun's transition from a legacy structures manufacturer to a high-growth aerospace and defense technology provider. Hitting these targets proves the company is successfully capturing demand from the humanoid robotics and defense upgrade cycles, justifying a valuation multiple expansion toward premium peers like Curtiss-Wright and RBC Bearings. | 2026-02-19 |
| Backlog | To trigger a valuation rerating, Ducommun needs to report a total backlog exceeding $1.05 billion, surpassing its previous record high. This requires the sequential backlog growth rate to accelerate from the current 1.8% to at least 5.0%, supported by a book-to-bill ratio of 1.15x or higher. Investors are looking for this growth to be driven by high-margin defense electronics and the 'Humanoid Actuator' hardware segment rather than just legacy structural components. | Backlog is the primary indicator of revenue visibility for Ducommun's 'Vision 2027' strategy. Reaching record levels proves that the company has successfully pivoted to high-growth robotics and defense markets, offsetting commercial aerospace volatility. This visibility justifies a multiple expansion toward premium aerospace peers like Curtiss-Wright and RBC Bearings. | 2026-02-19 |
| Adjusted EBITDA | Ducommun needs to demonstrate a significant recovery from the current 8.9% toward its 'Vision 2027' target of 20%. For a stock rerating, the Adjusted EBITDA margin must hit a threshold of 14.5% to 15.5%, supported by a book-to-bill ratio above 1.1x and guidance confirming a trajectory toward 18% by late 2026. This requires successful execution in high-margin electronic systems and defense-related actuator hardware to offset legacy structural costs. | DCO trades at a valuation discount to aerospace peers due to inconsistent margin execution. Hitting 15% validates the 'Vision 2027' strategy and the company's ability to monetize high-value robotics and defense backlogs. This expansion proves operational leverage, narrowing the gap with higher-multiple precision component suppliers. | 2026-02-19 |
Earnings Transcript Summary
· 2025Q4 Earnings Call
| 3 Things Management Is Most Focused On | Call Takeaway & Tone | Prior Quarter'S Y/Y Growth By Segment | 3 Things Analysts Most Pressed On (And Mgmt Responses) | Revenue Segments |
|---|---|---|---|---|
| 1. Executing the Vision 2027 game plan: Management is focused on increasing the revenue percentage of engineered products and aftermarket content, consolidating the rooftop footprint, continuing focused acquisition programs, executing offloading strategies with defense primes, driving value-added pricing, and expanding content on key commercial aerospace platforms. 2. Driving gross and adjusted EBITDA margins: The company aims to achieve and exceed Vision 2027 goals for margins, with Q4 2025 showing record levels. 3. Capitalizing on strong defense business and commercial aerospace recovery: Management is optimistic about continued strength in the defense business, particularly in missiles, and a recovery in commercial aerospace in the second half of 2026 as destocking issues resolve and build rates increase. | The overall takeaway of the call is positive and optimistic, with management highlighting record revenues, gross margins, and adjusted EBITDA margins in Q4 2025. The company is making strong progress towards its Vision 2027 goals, driven by robust performance in military and space, and an anticipated recovery in commercial aerospace. Management expressed confidence in future growth, particularly from increased defense spending and commercial build rates, and is actively pursuing M&A opportunities. The tone was confident and forward-looking, despite acknowledging ongoing destocking challenges in commercial aerospace and the impact of a litigation settlement on GAAP earnings. | Total Revenue (Q3 2025): 6% year-over-year growth. Military and Space (Q3 2025): 13% year-over-year growth. Commercial Aerospace (Q3 2025): 10% year-over-year decline. Structural Systems segment (Q3 2025): 4.0% year-over-year growth. Electronic Systems segment (Q3 2025): 6.6% year-over-year growth. | 1. Inventory destocking on the MAX and working capital movements: Analysts inquired about the magnitude of headwinds for H1 2026. Management responded that expectations for destocking are in line with previous comments, with external destocking primarily in the first half at Spirit and Boeing Direct, while internal destocking helps reduce working capital. 2. Medium-term opportunities in the defense side, especially with increased prime investment in capacity: Analysts asked about Ducommun's potential to grow faster than the market. Management stated that they have at least 30% room in their factories for missile increases without significant growth CapEx, and they are well-positioned as existing suppliers on major missile programs, expecting a major move in 2027. 3. M&A market activity and the $75 million revenue contribution placeholder from M&A for Vision 2027: Analysts asked about the M&A market and if the $75 million target could be met organically. Management confirmed increased M&A activity, noting it's competitive but they remain disciplined. They also stated that reaching the Vision 2027 revenue range will definitely require the M&A piece, as commercial aerospace recovery has been slower than initially expected. | Total Revenue: 9.4% year-over-year growth. Military and Space: 13% year-over-year growth. Commercial Aerospace: 1% year-over-year growth. Structural Systems segment: Approximately 6.7% year-over-year growth. Electronic Systems segment: Approximately 12.1% year-over-year growth. |
Transcript Tidbits
| About Expanding Eligible Market | About Competition | About The Broader Industry | Where Things Are Headed | Updates On Theme | Broader Themes Emerging | Bullish-Leaning Quotes (Short) | Bearish-Leaning Quotes (Short) | Hiring |
|---|---|---|---|---|---|---|---|---|
| Ducommun is increasing its revenue percentage from engineered products and aftermarket content, reaching 23% in 2025, up from 15% in 2022. The company is pursuing a focused acquisition program and executing an offloading strategy with defense primes in high-growth segments. They are also expanding content on key commercial aerospace platforms. The military and space segment showed double-digit growth for the fourth consecutive quarter, and the commercial aerospace segment returned to growth in Q4 2025. Remaining Performance Obligations (RPOs) reached a new record of $1.1 billion, with growth primarily in defense missiles. Notable wins include over $80 million in orders for the MIR program. The missile business grew 20% in 2025 and is expected to continue this trend, with over $130 million in orders booked in Q4 2025 across platforms like MIR, Tomahawk, AMRAAM, Standard Missiles, and THAAD. Ducommun is a supplier on over a dozen key missile platforms. Commercial aerospace revenue increased 1% year-over-year in Q4 2025, driven by growth in 787, A320, and in-flight entertainment. The company anticipates benefiting from Boeing's increased 737 MAX build rates (from 38 to 42, then 47) and 787 production ramp-up to 10 per month by year-end, with DCO having $150,000 per shipset content on the 787. Ducommun is also partnering with primes on hypersonics and counter-hypersonic programs, primarily on the electronics side with interconnects. Missiles represent about one-quarter of their defense business, with significant future opportunities. The potential for a $1.5 trillion defense budget presents a great overall opportunity for DCO, and they are building relationships for new warfare programs like CCA and hypersonics. | The M&A market is competitive with high valuations, but Ducommun remains disciplined. The company emphasizes strong relationships with defense primes, being critical to their success, and sole-sourcing many items. They have also worked to build relationships with other primes like Northrop Grumman and Lockheed Martin, diversifying beyond a heavy reliance on Raytheon. | The industry faces cyclicality in end-use markets, influenced by U.S. government defense spending, customer production rate changes, and order timing. Economic and geopolitical developments, including supply chain issues, international trade restrictions, tariffs, and elevated interest rates, are factors. The Department of War's push to ramp up missile production capacity, driven by demand to replenish stockpiles and FMS orders, is a significant trend. Boeing is increasing 737 MAX and 787 build rates, while Airbus is working through engine issues. The broader context includes rising AI-related capital expenditure in robotics, defense, aerospace, and industrial automation, and secular robotics adoption requiring high-end components. | Ducommun is entering the fourth year of its Vision 2027 game plan on strong footing, with plans to present its next 5-year vision (Vision 2032) in September. Bookings momentum is expected to continue in 2026. Restructuring initiatives are projected to yield $11 million to $13 million in annual savings by the end of 2026, with about half already realized and the remainder expected in 2026 as facilities reach full production rates. Adjusted EBITDA margins expanded to 16.4% in 2025, progressing towards the Vision 2027 target of 18%. For 2026, mid- to high single-digit revenue growth is expected, ramping up in the second half after a low to mid-single-digit first half. Defense business strength and commercial aerospace recovery are anticipated in the second half of 2026, once destocking subsides. The Department of War's push to increase missile production is seen as a strong catalyst for growth in the military and space segment starting in 2027 and beyond. Destocking for MAX products is expected to persist through the first half of 2026 and gradually ebb in the back half. The company is optimistic about commercial aerospace in 2026 and beyond. Achieving the $75 million M&A revenue contribution for Vision 2027 will likely require further acquisitions due to the slower-than-expected commercial aerospace recovery pace. The longer-term outlook for defense is very strong, but not all growth will materialize in 2026 and 2027. | Actuator | Increased global defense spending driven by geopolitical developments, the strategic importance of missile production capacity and replenishment, and the broader trend of AI-related capital expenditure driving demand in robotics and industrial automation. Reshoring of manufacturing is also implicitly supported by Ducommun's domestic operations. | Vision 2027 game plan... on very strong footing. Q4 2025 results show again that strategy and initiatives are working. gross and adjusted EBITDA margins at record levels. 19th consecutive quarter with year-over-year growth in revenue. RPOs grew to a new record level of $1.1 billion. book-to-bill overall was 1.3x in Q4, a great result. tremendous progress in the past 3 years and a terrific job by the DCO team. strong confidence in the momentum from both our primary end markets. DCO is well positioned as an existing supplier with defense primes on all these programs. missile business grew 20% compared to 2024, and we expect this trend to continue. We can't wait. We're waiting for the year. Our defense business is strong. It's only going to get stronger. It's only going to get bigger. | commercial aerospace segment, which has been challenged all year due to destocking. destocking at BA and SPR headwind all year. commercial aerospace business declined... by 7%. The production outlook at that point in time versus reality today is very different. It is competitive. There are -- and valuations are not cheap. Industrial cycle remains fragile; if AI capex slows or gets delayed, near-term demand could soften. Execution risk: supply chain, tariffs, and workforce scaling may prevent companies from fully monetizing AI-linked demand. |
Earnings ResultsDucommun reported record quarterly revenue of $215.8 million, representing 9.4% year-over-year growth, which falls within the target range of 8% to 10% and exce
| Metric | Prior Quarter | Rerating Trigger | Actual Reported | Hit Target? | Notes |
|---|---|---|---|---|---|
| Total Revenue | 1.1% | To achieve a higher rerating, Ducommun needs to demonstrate revenue growth acceleration to a range of 8% to 10% year-over-year, effectively moving past the current stagnant 1.1% level. Specifically, the company needs to report quarterly revenue exceeding $215 million, which would represent a 3-5% beat over current consensus estimates. This growth must be driven by organic expansion in the Electronic Systems segment, particularly within high-margin motion control and actuator hardware, to align with the 'Vision 2027' target of $950M-$1B in annual revenue. | $215.8 million (9.4% y/y growth) | Yes | Ducommun reported record quarterly revenue of $215.8 million, representing 9.4% year-over-year growth, which falls within the target range of 8% to 10% and exceeds the $215 million threshold. This marks the company's 19th consecutive quarter of year-over-year revenue growth. |
| Backlog | 1.8% | To trigger a valuation rerating, Ducommun needs to report a total backlog exceeding $1.05 billion, surpassing its previous record high. This requires the sequential backlog growth rate to accelerate from the current 1.8% to at least 5.0%, supported by a book-to-bill ratio of 1.15x or higher. Investors are looking for this growth to be driven by high-margin defense electronics and the 'Humanoid Actuator' hardware segment rather than just legacy structural components. | $1.1 billion (7.32% sequential growth) | Yes | The company's remaining performance obligations (RPOs), which represent backlog, grew to a new record level of $1.1 billion, increasing $75 million sequentially. This translates to a sequential growth rate of approximately 7.32%, exceeding the 5.0% target. The book-to-bill ratio for Q4 was 1.3x, also surpassing the 1.15x threshold. |
| Adjusted EBITDA | 8.9% | Ducommun needs to demonstrate a significant recovery from the current 8.9% toward its 'Vision 2027' target of 20%. For a stock rerating, the Adjusted EBITDA margin must hit a threshold of 14.5% to 15.5%, supported by a book-to-bill ratio above 1.1x and guidance confirming a trajectory toward 18% by late 2026. This requires successful execution in high-margin electronic systems and defense-related actuator hardware to offset legacy structural costs. | 17.5% (+3.7pp y/y) | Yes | Ducommun achieved an Adjusted EBITDA margin of 17.5% in Q4 2025, which is well above the rerating threshold of 14.5% to 15.5%. This represents a 3.7 percentage point increase from the 13.84% Adjusted EBITDA margin in Q4 2024. The company's book-to-bill ratio of 1.3x also supported this metric. Management noted that the Q4 margin included a 100 basis point benefit from product mix but still represented tremendous progress. They also reiterated confidence in achieving the Vision 2027 target of 18% EBITDA margin. |
Notes
| Date | Comment | Comment Type | Comment Sentiment | Link | IS CHANGE | Price Reaction |
|---|---|---|---|---|---|---|
| 2026-02-26 | Ducommun reported record Q4 2025 revenue and strong adjusted EPS, beating estimates, driven by robust military/space growth and margin expansion. However, revenue slightly missed forecasts, and despite positive operational messaging and a strong outlook for 2026, the stock fell 5.5% post-earnings. This suggests market concerns over the revenue miss and trailing twelve-month profitability overshadowed the strong quarterly performance. | Other | Neutral | False | Deferred (realtime snapshot stale) |
Upcoming Events
| Catalyst ID | Estimated Timing | Estimated Date Start | Estimated Date End | Catalyst | Why It Matters | Ticker Or Theme Specific | Transcript Date | Source Type |
|---|---|---|---|---|---|---|---|---|
| DCO_8fd813d6 | this September in New York on the 17th | 2026-09-17 | 2026-09-17 | Ducommun will hold an investor conference to present its next 5-year strategic vision, 'Vision 2032', as a follow-up to the current Vision 2027 plan. | The new vision will outline the company's long-term strategic direction and financial goals, which could significantly impact investor sentiment and future valuation. | Ticker | 2026-02-26 | earnings_transcript |
| DCO_70f5610d | further ramp in 2026 as the receiving facilities move up the learning curve and move to full rate production | 2026-01-01 | 2026-12-31 | Full realization of the remaining $6 million to $7 million in annual cost savings from the facility consolidation and restructuring program, as product lines reach full rate production at new facilities. | These cost savings are expected to directly improve gross and adjusted EBITDA margins, contributing to the achievement of the company's Vision 2027 margin targets. | Ticker | 2026-02-26 | earnings_transcript |
| DCO_74f4adec | during the second half once we get through destocking | 2026-07-01 | 2026-12-31 | Recovery in the commercial aerospace business as destocking at Boeing and Spirit on the 737 MAX ebbs and Boeing increases 737 MAX and 787 build rates. | This recovery will remove a significant headwind, drive overall revenue growth for Ducommun, and potentially improve product mix and margins in the commercial aerospace segment. | Ticker | 2026-02-26 | earnings_transcript |
| DCO_04370839 | starting in 2027 and beyond | 2027-01-01 | 2029-12-31 | Significant ramp-up in missile production by defense primes like Raytheon and Lockheed Martin, driven by long-term framework agreements and Department of Defense initiatives. | Ducommun is a key supplier on these missile programs and expects this ramp-up to be a major driver for growth in its military and space segment, significantly boosting future revenue and profitability. | Ticker | 2026-02-26 | earnings_transcript |
| DCO_88c060be | More to come on that | 2026-02-27 | 2027-12-31 | Ducommun's execution of its acquisition strategy to achieve the $75 million revenue contribution placeholder for its Vision 2027 goals. | Successful M&A execution is crucial for accelerating revenue growth, expanding the engineered products portfolio, and meeting the company's Vision 2027 financial targets. | Ticker | 2026-02-26 | earnings_transcript |